Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3ß signaling and inhibition of cellular prostatic acid phosphatase.
Cancer Lett
; 449: 252-262, 2019 05 01.
Article
in En
| MEDLINE
| ID: mdl-30790678
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Acid Phosphatase
/
Omeprazole
/
Receptor, ErbB-2
/
Mitogen-Activated Protein Kinase 1
/
Mitogen-Activated Protein Kinase 3
/
Cell Proliferation
/
Proto-Oncogene Proteins c-akt
/
Proton Pump Inhibitors
/
Phosphatidylinositol 3-Kinase
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Cancer Lett
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: